Influenza Therapeutics Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Size, Share & Trends, Drivers, Restraints, Opportunities, Manufacturer, Applications, And Segments

  • AMR-1064541
  • May 2021
  • Pharmaceuticals
  • 116 Pages
The Influenza Therapeutics Market research report comprises of an overall in depth-analysis such as market drivers, opportunities, restraints, latest developments and trends, segmentation of the market, competitive analysis, global as well as regional analysis by showcasing how each of these factors can improve the further growth of the market on an overall perspective. The report also showcases the overall market value which includes the historic data (2018-2019) and forecast data (2020-2028) generated through the revenue (USD Mn)
 
Report Parameters Details of Parameter
Market Size xx Million
Based Year 2020
Forecast Period Covered 2020 – 2028
Units for value Revenue in USD million and CAGR from 2020 to 2028
Covered Segments Component, Types, Applications, End-Users, and more.
Companies Covered Abbott, Sanofi SA, CSL Limited, Glaxosmithkline PLC, Daiichi Sankyo Co., Ltd., Roche Holding AG, Biocryst Pharmaceuticals, Inc., Sinovac Biotech Ltd., Mitsubishi Tanabe Pharma Corporation
Region Covered North America, Europe, Asia Pacific, Latin America, Middle East and Africa

COVID-19 Coverage
With the beginning of the COVID-19 pandemic in early 2020, all major economies around the world enforced severe lockdown restrictions to curb the spread of the virus. Apart from a few sectors such as healthcare and related essential services, most of the industries suffered tremendously due to inability to function in a normal fashion. Moreover, even some of the essential sectors suffered due to delays caused by supply chain disruptions and other travel complexities. However, with massive vaccination drives in most of the developed economies, some of the economies across the world experienced economic recovery from 2021. The Influenza Therapeutics market is expected to gain momentum in such economies and probably recover some of the losses inflicted in the year 2020. With continued efforts towards curbing the virus in the developing economies, the Influenza Therapeutics market is expected to attain Pre COVID-19 levels by mid-2022.

Influenza Therapeutics Report’s Assessment
The research report is formulated such that it offers a deep understating on the market drivers that are assimilating the growth of the market, the market opportunities that are going to provide future growth factors for the market and the market restraints which showcase the reasons as to why the market can get hampered and dissimilated. All these factors are considered keeping in view the historic and forecast analysis which can enlighten the above mentioned factors.

Thereby at a glance a reader can understand all the factors and prospects of the Influenza Therapeutics market and how it can assimilate and dissimilate based on each of the factors and figures mentioned in the report

Influenza Therapeutics Market Competitive and Premeditated Analysis
In the Influenza Therapeutics report major factors such latest tactical developments, competitors, research and development, participation of each region in the market and the competition among them, the latest news regarding company acquisitions and product launch, revenue of the competitors as well as the key offerings they provide all these factors are mentioned in the report with reasons to justify and understand them in depth.

The readers and purchaser of the Influenza Therapeutics research report can gain a comprehensive understanding of the market competition, the revenue of each major players and their contribution towards the market, attractive proposition analysis is provided in the report which sub divides the segments with respect to the largest segment that has contributed to the market growth and the fastest growing segment based on the size of the market as well as its overall appeal.
 
Major Key Players for Global Influenza Therapeutics Market:
The Influenza Therapeutics market research report offers the company profile of major key players including progress trends, competitive landscape breakdown, and key in regions development status. Abbott, Sanofi SA, CSL Limited, Glaxosmithkline PLC, Daiichi Sankyo Co., Ltd., Roche Holding AG, Biocryst Pharmaceuticals, Inc., Sinovac Biotech Ltd., Mitsubishi Tanabe Pharma Corporation

The Influenza Therapeutics market report showcases vast potentials of growth and assimilation which is going to provide the industry numerous opportunities to grow and generate revenue by understanding the segments and which segment is a potential part to increase the disposable income in the present and upcoming years.

Influenza Therapeutics Market Segmentation Analysis:
Each of the segment is explained in brief along with the revenue it generates for the market based on the historic and forecast data by highlighting the largest segment and the fastest growing segment with reasons to justify it.

The Global segmentation of the Influenza Therapeutics market:
by Therapy Type
Drug
Vaccines

Regional Analysis of the Influenza Therapeutics market:
The Influenza Therapeutics market is dived based on different regions such as North America, Europe, Asia Pacific, Latin America and the Middle East and Africa. And the analysis of each region is provided by highlighting the largest contribution region, the fastest growing region and the factors that is keeping the market active in the other regions is also mentioned in depth. Each regional segment also comprises of the revenue each segment holds in a specific region with reasons to justify the values.

By Regions:
  • North America (U.S and Canada)
  • Europe (U.K., Germany and France)
  • Asia Pacific (China, India and Japan)
  • Latin America (Mexico and Brazil)
  • Middle East and Africa (GCC Countries and South Africa)
 


Major Factors Included and highlighted in the Influenza Therapeutics report are as follows:
  • The overall market value along with historic and future data analysis.
  • The Growth drivers, opportunities and restraints are mention in detail.
  • The size of the entire Influenza Therapeutics market on a global perspective.
  • The CAGR value of the overall market from 2020 to 2028.
  • COVID-19 impact on the Influenza Therapeutics market and how it is coping up with the situation.
  • Major competitors and their contribution towards the market.
  • The segmentation analysis is included which provides a clear picture of the market bifurcation.
  • Tables and graphs that can easily been understood at a glance
  • Latest trends and news related to the Influenza Therapeutics market is included in the report.
Key Analytical Areas:
The report aims to offer a complete solution to various businesses operating in the Influenza Therapeutics market in making strategic decisions based on credible information and actionable insights. Thereby, the report covers various aspects of your requirements such as industry overview, market dynamics, regional analysis and competitive landscape. The report aims to provide insights to businesses in the Influenza Therapeutics market for numerous purposes such as:

     1. Strategic Decision Making:
With the help of this report, key decision makers can quickly analyze and identify growth opportunities in terms of numerous segments across various geographical regions. Thereby, this report enables organizations to identify and make strategic investments in specific market segments in order to gain maximum return on investment.

     2. Actionable Insights:
The report offers a deep dive into how companies are leveraging market conditions to make the most in the Influenza Therapeutics market. Thereby, the report offers numerous actionable insights into the best practices and key success factors relevant in the Influenza Therapeutics market. Using the insights included in the report, businesses can make quick decisions to achieve success in business operations.

     3. Competitive Snapshot:
In addition, to detailed information on the companies operating in the Influenza Therapeutics market, the report also includes a competitive snapshot of all the companies covered in the report. Thereby, this offers a visual representation of how all the companies stand comparatively based on their competencies, geographic presence, market hold, years of operations, employee and financial strength, among others.

Manufacturers and Segments

  • Abbott
  • Sanofi SA
  • CSL Limited
  • Glaxosmithkline PLC
  • Daiichi Sankyo Co., Ltd.
  • Roche Holding AG
  • Biocryst Pharmaceuticals, Inc.
  • Sinovac Biotech Ltd.
  • Mitsubishi Tanabe Pharma Corporation
  • Drug
  • Vaccines
  • Drug
  • Vaccines

Have query on this report?

Make an Enquiry
1. Preface
     1.1. Report Scope and Description
     1.2. Research Methodology
          1.2.1. Phase I-Secondary Research
          1.2.2. Phase II-Primary Research
          1.2.3. Phase II-Expert Panel Review
          1.2.4. Assumptions
          1.2.5. Approach Adopted

2. Executive Summarysegment Form
     2.1. Global Influenza Therapeutics Market Snapshot
          2.1.1. Global Influenza Therapeutics Market By Therapy Type,2019
               2.1.1.1.Drug
               2.1.1.2.Vaccines
          2.1.2. Global Influenza Therapeutics Market By Therapy Type,2019
               2.1.2.1.Drug
               2.1.2.2.Vaccines
          2.1.3. Global Influenza Therapeutics Market By End-use,2019
          2.1.4. Global Influenza Therapeutics Market By Geography,2019

3. Global Influenza Therapeutics Market Dynamics
     3.1. Market Overview
     3.2. Market Inclination Insights Analysis
     3.3. Drivers
     3.4. Challenges
     3.5. Future Prospects
     3.6. Impact Analysis of Drivers and Challenges During the Forecast Period, (2020-2028)

4. Global Influenza Therapeutics Market Size (US$), By Therapy Type, 2018 – 2028 
     4.1. Overview
          4.1.1. Market Share Analysis By Therapy Type, 2019 vs.2028
          4.1.2. Attractive Investment Proposition By Therapy Type, 2020
     4.2. Global Influenza Therapeutics Market Size (US$), By Therapy Type, 2018 – 2028

5. Global Influenza Therapeutics Market Size (US$), By Therapy Type, 2018 – 2028 
     5.1. Overview
          5.1.1. Market Share Analysis By Therapy Type, 2019 vs.2028
          5.1.2. Attractive Investment Proposition By Therapy Type, 2020
     5.2. Global Influenza Therapeutics Market Size (US$), By Therapy Type, 2018 – 2028

6. Global Influenza Therapeutics Market Size (US$), By End-use, 2018 – 2028 
     6.1. Overview
          6.1.1. Market Share Analysis By End-use, 2019 vs.2028
          6.1.2. Attractive Investment Proposition By End-use, 2020
     6.2. Global Influenza Therapeutics Market Size (US$), By End-use, 2018 – 2028

7. Global Influenza Therapeutics Market Size (US$), By Geography, 2018 – 2028
     7.1. Overview
          7.1.1. Market Share Analysis by Geography, 2019 vs. 2028
          7.1.2. Attractive Investment Proposition by Geography, 2020
     7.2. North America Influenza Therapeutics Market Analysis, 2018 – 2028 
          7.2.1. North America Influenza Therapeutics Market Size (US$), By Country, 2018 – 2028 
               7.2.1.1. U.S.
               7.2.1.2. Canada
          7.2.2. North America Influenza Therapeutics Market Size (US$), By Therapy Type, 2018 – 2028
          7.2.3. North America Influenza Therapeutics Market Size (US$), By Therapy Type, 2018 – 2028
          7.2.4. North America Influenza Therapeutics Market Size (US$), By End-use, 2018 – 2028
     7.3. Europe Influenza Therapeutics Market Analysis, 2018 – 2028 
          7.3.1.  Europe Influenza Therapeutics Market Size (US$), By Country, 2018 – 2028 
               7.3.1.1. U.K.
               7.3.1.2. Germany
               7.3.1.3. France
               7.3.1.4. Rest of Europe
          7.3.2. Europe Influenza Therapeutics Market Size (US$), By Therapy Type, 2018 – 2028
          7.3.3. Europe Influenza Therapeutics Market Size (US$), By Therapy Type, 2018 – 2028
          7.3.4. Europe Influenza Therapeutics Market Size (US$), By End-use, 2018 – 2028
     7.4. Asia Pacific Influenza Therapeutics Market Analysis , 2018 – 2028
          7.4.1.  Asia Pacific Influenza Therapeutics Market Size (US$), By Country, 2018 – 2028 
               7.4.1.1. China
               7.4.1.2. Japan
               7.4.1.3. India
               7.4.1.4. Rest of Asia Pacific
          7.4.2. Asia Pacific Influenza Therapeutics Market Size (US$), By Therapy Type, 2018 – 2028
          7.4.3. Asia Pacific Influenza Therapeutics Market Size (US$), By Therapy Type, 2018 – 2028
          7.4.4. Asia Pacific Influenza Therapeutics Market Size (US$), By End-use, 2018 – 2028
     7.5. Latin America Influenza Therapeutics Market Analysis, 2018 – 2028 
          7.5.1.  Latin America Influenza Therapeutics Market Size (US$), By Country, 2018 – 2028 
               7.5.1.1. Brazil
               7.5.1.2. Mexico
               7.5.1.3. Rest of Latin America
          7.5.2. Latin America Influenza Therapeutics Market Size (US$), By Therapy Type, 2018 – 2028
          7.5.3. Latin America Influenza Therapeutics Market Size (US$), By Therapy Type, 2018 – 2028
          7.5.4. Latin America Influenza Therapeutics Market Size (US$), By End-use, 2018 – 2028
     7.6. Middle East & Africa (MEA) Influenza Therapeutics Market Analysis, 2018 – 2028 
          7.6.1.  MEA Influenza Therapeutics Market Size (US$), By Region, 2018 – 2028 
               7.6.1.1. GCC Countries
               7.6.1.2. South Africa
               7.6.1.3. Rest of MEA
          7.6.2. MEA Influenza Therapeutics Market Size (US$), By Therapy Type, 2018 – 2028
          7.6.3. MEA Influenza Therapeutics Market Size (US$), By Therapy Type, 2018 – 2028
          7.6.4. MEA Influenza Therapeutics Market Size (US$), By End-use, 2018 – 2028

8. Company Profiles
     8.1. Competitive Analysis 
     8.2. Market Positioning of Key Vendors 
     8.3. Key Strategies adopted by the Leading Players
     8.4. Key Influenza Therapeutics Providers
        8.4.1 Abbott
                8.4.1.1 Business Description
                8.4.1.2 Abbott Geographic Operations
                8.4.1.3 Abbott Financial Information
                8.4.1.4 Abbott Product Positions/Portfolio
                8.4.1.5 Abbott Key Developments
        8.4.2 Sanofi SA
                8.4.2.1 Business Description
                8.4.2.2 Sanofi SA Geographic Operations
                8.4.2.3 Sanofi SA Financial Information
                8.4.2.4 Sanofi SA Product Positions/Portfolio
                8.4.2.5 Sanofi SA Key Developments
        8.4.3 CSL Limited
                8.4.3.1 Business Description
                8.4.3.2 CSL Limited Geographic Operations
                8.4.3.3 CSL Limited Financial Information
                8.4.3.4 CSL Limited Product Positions/Portfolio
                8.4.3.5 CSL Limited Key Developments
        8.4.4 Glaxosmithkline PLC
                8.4.4.1 Business Description
                8.4.4.2 Glaxosmithkline PLC Geographic Operations
                8.4.4.3 Glaxosmithkline PLC Financial Information
                8.4.4.4 Glaxosmithkline PLC Product Positions/Portfolio
                8.4.4.5 Glaxosmithkline PLC Key Developments
        8.4.5 Daiichi Sankyo Co., Ltd.
                8.4.5.1 Business Description
                8.4.5.2 Daiichi Sankyo Co., Ltd. Geographic Operations
                8.4.5.3 Daiichi Sankyo Co., Ltd. Financial Information
                8.4.5.4 Daiichi Sankyo Co., Ltd. Product Positions/Portfolio
                8.4.5.5 Daiichi Sankyo Co., Ltd. Key Developments
        8.4.6 Roche Holding AG
                8.4.6.1 Business Description
                8.4.6.2 Roche Holding AG Geographic Operations
                8.4.6.3 Roche Holding AG Financial Information
                8.4.6.4 Roche Holding AG Product Positions/Portfolio
                8.4.6.5 Roche Holding AG Key Developments
        8.4.7 Biocryst Pharmaceuticals, Inc.
                8.4.7.1 Business Description
                8.4.7.2 Biocryst Pharmaceuticals, Inc. Geographic Operations
                8.4.7.3 Biocryst Pharmaceuticals, Inc. Financial Information
                8.4.7.4 Biocryst Pharmaceuticals, Inc. Product Positions/Portfolio
                8.4.7.5 Biocryst Pharmaceuticals, Inc. Key Developments
        8.4.8 Sinovac Biotech Ltd.
                8.4.8.1 Business Description
                8.4.8.2 Sinovac Biotech Ltd. Geographic Operations
                8.4.8.3 Sinovac Biotech Ltd. Financial Information
                8.4.8.4 Sinovac Biotech Ltd. Product Positions/Portfolio
                8.4.8.5 Sinovac Biotech Ltd. Key Developments
        8.4.9 Mitsubishi Tanabe Pharma Corporation
                8.4.9.1 Business Description
                8.4.9.2 Mitsubishi Tanabe Pharma Corporation Geographic Operations
                8.4.9.3 Mitsubishi Tanabe Pharma Corporation Financial Information
                8.4.9.4 Mitsubishi Tanabe Pharma Corporation Product Positions/Portfolio
                8.4.9.5 Mitsubishi Tanabe Pharma Corporation Key Developments

LIST OF TABLES

TABLE 1 Market Snapshot: Global Influenza Therapeutics Market 
TABLE 2 Impact Indicators 
TABLE 3 Impact Analysis of Drivers and Restraints 
TABLE 4 North America Influenza Therapeutics Market Revenue, By Therapy Type, 2018 – 2028 (US$ Mn) 
TABLE 5 North America Influenza Therapeutics Market Revenue, By Therapy Type, 2018 – 2028 (US$ Mn) 
TABLE 6 North America Influenza Therapeutics Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 7 Europe Influenza Therapeutics Market Revenue, By Therapy Type, 2018 – 2028 (US$ Mn) 
TABLE 8 Europe Influenza Therapeutics Market Revenue, By Therapy Type, 2018 – 2028 (US$ Mn) 
TABLE 9 Europe Influenza Therapeutics Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 10 Asia Pacific Influenza Therapeutics Market Revenue, By Therapy Type, 2018 – 2028 (US$ Mn) 
TABLE 11 Asia Pacific Influenza Therapeutics Market Revenue, By Therapy Type, 2018 – 2028 (US$ Mn) 
TABLE 12 Asia Pacific Influenza Therapeutics Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 13 Latin America Influenza Therapeutics Market Revenue, By Therapy Type, 2018 – 2028 (US$ Mn) 
TABLE 14 Latin America Influenza Therapeutics Market Revenue, By Therapy Type, 2018 – 2028 (US$ Mn) 
TABLE 15 Latin America Influenza Therapeutics Market Revenue, By End-use, 2018 – 2028 (US$ Mn)
TABLE 16 MEA Influenza Therapeutics Market Revenue, By Therapy Type, 2018 – 2028 (US$ Mn) 
TABLE 17 MEA Influenza Therapeutics Market Revenue, By Therapy Type, 2018 – 2028 (US$ Mn) 
TABLE 18 MEA Influenza Therapeutics Market Revenue, By End-use, 2018 – 2028 (US$ Mn)

LIST OF FIGURES

FIG. 1 Global Influenza Therapeutics: Market Segmentation 
FIG. 2 Global Influenza Therapeutics Market: Research Methodology 
FIG. 3 Top-Down and Bottom-up Approach 
FIG. 4 Global Influenza Therapeutics Market, By Therapy Type, 2019 (US$ Mn) 
FIG. 5 Global Influenza Therapeutics Market, By Therapy Type, 2019 (US$ Mn) 
FIG. 6 Global Influenza Therapeutics Market, By End-use, 2019 (US$ Mn) 
FIG. 7 Global Influenza Therapeutics Market, By Geography, 2019 (US$ Mn) 
FIG. 8 Global Influenza Therapeutics Market Revenue and Growth, 2018 – 2028, (US$ Mn) (Y-o-Y %)
FIG. 9 Attractive Investment Proposition 
FIG. 10 Market Positioning of Key Influenza Therapeutics Providers, 2019
FIG. 11 Global Influenza Therapeutics Market Revenue Contribution, By Therapy Type, 2019 & 2028 (Value %) 
FIG. 12 Global Influenza Therapeutics Market Revenue Contribution, By Therapy Type, 2019 & 2028 (Value %) 
FIG. 13 Global Influenza Therapeutics Market Revenue Contribution, By End-use, 2019 & 2028 (Value %) 
FIG. 14 North America Influenza Therapeutics Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 15 Europe Influenza Therapeutics Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 16 Asia Pacific Influenza Therapeutics Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 17 Latin America Influenza Therapeutics Market Revenue, 2018 – 2028, (US$ Mn)
FIG. 18 MEA Influenza Therapeutics Market Revenue, 2018 – 2028, (US$ Mn)

Key Takeaways:

1. Market value and estimate of the Influenza Therapeutics market for the period from 2020 to 2028
2. Compounded annual growth rate (CAGR%) for individual segments in various regional markets for a period from 2020 to 2028
3. Value chain analysis
4. Market share study combined with competitive landscape of major players
5. Profiles of major market players covering overall business operations, geographic occurrence, product portfolio, financial status and news coverage 

List of Tables

TABLE  Market Snapshot: Global Influenza Therapeutics Market
TABLE  Impact Pointers
TABLE  Impact Analysis of Drivers and Restraints
TABLE  North America Influenza Therapeutics Market Value, By Segment1, 2018 – 2028
TABLE  North America Influenza Therapeutics Market Value, By Segment2, 2018 – 2028
TABLE  North America Influenza Therapeutics Market Value, By Country, 2018 – 2028
TABLE  Europe Influenza Therapeutics Market Value, By Segment1, 2018 – 2028
TABLE  Europe Influenza Therapeutics Market Value, By Segment2, 2018 – 2028
TABLE  Europe Influenza Therapeutics Market Value, By Country, 2018 – 2028
TABLE  Asia Pacific Influenza Therapeutics Market Value, By Segment1, 2018 – 2028
TABLE  Asia Pacific Influenza Therapeutics Market Value, By Segment2, 2018 – 2028
TABLE  Asia Pacific Influenza Therapeutics Market Value, By Country, 2018 – 2028
TABLE  Latin America Influenza Therapeutics Market Value, By Segment1, 2018 – 2028
TABLE  Latin America Influenza Therapeutics Market Value, By Segment2, 2018 – 2028
TABLE  Latin America Influenza Therapeutics Market Value, By Country, 2018 – 2028
TABLE  MEA Influenza Therapeutics Market Value, By Segment1, 2018 – 2028
TABLE  MEA Influenza Therapeutics Market Value, By Segment2, 2018 – 2028
TABLE  MEA Influenza Therapeutics Market Value, By Country, 2018 – 2028
TABLE  Abbott: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Sanofi SA: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  CSL Limited: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Glaxosmithkline PLC: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Daiichi Sankyo Co., Ltd.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Roche Holding AG: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Biocryst Pharmaceuticals, Inc.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Sinovac Biotech Ltd.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Mitsubishi Tanabe Pharma Corporation: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
 

List of Figures

FIG.  Global Influenza Therapeutics Market: Research Methodology
FIG.  Top-Down and Bottom Up Approach
FIG.  Global Influenza Therapeutics Market, By Segment1, 2019 (US$ Mn)
FIG.  Global Influenza Therapeutics Market, By Segment2, 2019 (US$ Mn)
FIG.  Global Influenza Therapeutics Market, By Geography, 2019 (US$ Mn)
FIG.  Global Influenza Therapeutics Market Value and Growth, 2018 – 2028, (US$ Mn) (Y-o-Y %)
FIG.  Attractive Investment Proposition
FIG.  Market Positioning of Key Influenza Therapeutics Providers, 2016
FIG.  Global Influenza Therapeutics Market Value Share, By Segment1, 2019 & 2028 (% Value)
FIG.  Global Vaccines Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Influenza Therapeutics Market Value Share, By Segment2, 2019 & 2028 (% Value)
FIG.  Global Vaccines Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Market Value, 2018 – 2028, (US$ Mn)
FIG.  U.S. Influenza Therapeutics Market Value, 2018 – 2028, (US$ Mn)
FIG.  Canada Influenza Therapeutics Market Value, 2018 – 2028, (US$ Mn)
FIG.  UK Influenza Therapeutics Market Value, 2018 – 2028, (US$ Mn)
FIG.  Germany Influenza Therapeutics Market Value, 2018 – 2028, (US$ Mn)
FIG.  France Influenza Therapeutics Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of Europe Influenza Therapeutics Market Value, 2018 – 2028, (US$ Mn)
FIG.  China Influenza Therapeutics Market Value, 2018 – 2028, (US$ Mn)
FIG.  Japan Influenza Therapeutics Market Value, 2018 – 2028, (US$ Mn)
FIG.  India Influenza Therapeutics Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of Asia Pacific Influenza Therapeutics Market Value, 2018 – 2028, (US$ Mn)
FIG.  Mexico Influenza Therapeutics Market Value, 2018 – 2028, (US$ Mn)
FIG.  Brazil Influenza Therapeutics Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of Latin America Influenza Therapeutics Market Value, 2018 – 2028, (US$ Mn)
FIG.  GCC Countries Influenza Therapeutics Market Value, 2018 – 2028, (US$ Mn)
FIG.  South Africa Influenza Therapeutics Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of MEA Influenza Therapeutics Market Value, 2018 – 2028, (US$ Mn)